Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis

Yu Fujita,Ali Khateb,Yan Li,Roberto Tinoco,Tongwu Zhang,Haggai Bar-Yoseph,Miguel A. Tam,Yehuda Chowers,Edmond Sabo,Shiran Gerassy-Vainberg,Elina Starosvetsky,Brian James,Kevin Brown,Shai S. Shen-Orr,Linda M. Bradley,Philippe A. Tessier,Ze’ev A. Ronai
DOI: https://doi.org/10.1016/j.celrep.2018.08.057
IF: 8.8
2018-09-01
Cell Reports
Abstract:Inflammatory bowel disease (IBD) is prevalent, but the mechanisms underlying disease development remain elusive. We identify a role for the E3 ubiquitin ligase RNF5 in IBD. Intestinal epithelial cells (IECs) express a high level of RNF5, while the colon of Rnf5<sup>-/-</sup> mice exhibits activated dendritic cells and intrinsic inflammation. Rnf5<sup>-/-</sup> mice exhibit severe acute colitis following dextran sodium sulfate (DSS) treatment. S100A8 is identified as an RNF5 substrate, resulting in S100A8 ubiquitination and proteasomal-dependent degradation that is attenuated upon inflammatory stimuli. Loss of RNF5 from IECs leads to enhanced S100A8 secretion, which induces mucosal CD4<sup>+</sup> T cells, resulting in Th1 pro-inflammatory responses. Administration of S100A8-neutralizing antibodies to DSS-treated Rnf5<sup>-/-</sup> mice attenuates acute colitis development and increases survival. An inverse correlation between RNF5 and S100A8 protein expression in IECs of IBD patients coincides with disease severity. Collectively, RNF5-mediated regulation of S100A8 stability in IECs is required for the maintenance of intestinal homeostasis.
cell biology
What problem does this paper attempt to address?